key: cord-0993169-93kxeb50
authors: Rehman, Suriya; Majeed, Tariq; Azam Ansari, Mohammad; Ali, Uzma; Sabit, Hussein; Al-Suhaimi, Ebtesam A.
title: Current Scenario of COVID-19 in Pediatric Age Group and Physiology of Immune and Thymus response
date: 2020-05-15
journal: Saudi J Biol Sci
DOI: 10.1016/j.sjbs.2020.05.024
sha: f6043f6a64d409208fea9bf6010467a5164ba14e
doc_id: 993169
cord_uid: 93kxeb50

Abstract COVID-19 pandemic caused by SARS-CoV-2, continues to manifest with severe acute respiratory syndrome among the adults, however, it offers a convincing indication of less severity and fatality in pediatric age group (0-18 years). The current trend suggests that children may get infected but are less symptomatic with less fatality, which is concordant to earlier epidemic outbreaks of SARS-CoV and MERS-CoV, in 2002 and 2012, respectively. According to the available data, children appear to be at lower risk for COVID-19, as adults constitute for maximum number of the confirmed cases (308,592) and deaths (13,069) as on 22nd March ( https://www.worldometers.info/coronavirus ). However, rapid publications and information of the adult patients with COVID-19 is in progress and published, on the contrary, almost no comprehensive data or discussion about the COVID-19 in children is available. Therefore, in this review, we outline the epidemiology, clinical symptoms, diagnosis, treatment, prevention, possible immune response and role of thymus in children to combat the COVID-19 outbreak.

From last two decades, coronaviruses have led to three major outbreaks that started from 2002 with SARS-CoV, then MERS-CoV in 2012 and currently SARS-CoV-2 . The rapid spread of the disease around the globe which originated from Wuhan city of China, has been declared as pandemic by WHO on 11 March 2020. SARS-CoV-2 is a new human infecting Betacoronavirus belonging to a large family of zoonotic coronaviruses that are enveloped and single stranded RNA viruses, leading to zoonotic diseases. Zoonotic diseases, also called zoonosis are the diseases that are caused by the organisms/infective agents carried by the animals, transferred from animals to humans resulting in illnesses. They might belong to any class of viruses, bacteria, protozoa, and fungi. During these interactions, there are numerous ways these sources of infections like Coronaviruses, can be contracted to humans from animals via direct contact, food borne, water borne or vectors, resulting in zoonotic diseases (CDC July 2017). The commonly circulating corona viruses in humans are NL63, -HKU1, -OC43 and HCoV2-229E. Although CoVs can quickly bring mutations, leading to novel CoVs, that could transmit from animals to humans (Velavan and Meyer 2020) .

This virus comprises of densely glycosylated spike (S) proteins which enables it to penetrate and bind to the angiotensin-converting enzyme 2 receptor (ACE2) of the human host cell, similar as found previously in SARS-CoV (del Rio and Malani 2020) . The polyprotein 1ab (pp1ab), consists of nonstructural proteins 1-16, which is similar to other members of subgenus, Sarbecovirus.

Analysis of the pp1ab protein in COVID-19 showed that the protein sequence remains unchanged in samples studied from different locations during the outbreak. A unique deletion of eight amino acids in the virulence factor of the COVID-19 was detected in an isolate from an asymptomatic Japanese patient (Cardenas-Conejo et al. 2020) . Additionally, 42 amino acid signatures in the pp1ab was identified that was only present in . Such studies indicates that COVID-19 might have originated by genetic drift from a bat (bat-SL-CoV-RaTG13) (Cardenas-Conejo et al. 2020; . Genetic drift is a kind of mutation that results from a variation in the gene 4 pool over a period. It generally happens when alleles that are the variants of a gene either increase or decrease randomly with time (Honay et.al 2013) . It's been found that the effect of genetic drift is stronger in small population, that's why even a smaller event may result in larger impacts. The same is true for the pathogenicity of the microorganisms especially viruses, that frequently mutates, and impact of genetic drift is high (Kennedy et al 2018).

The other CoVs like HCoV2-229E, NL63, and OC43.15 which mostly circulate in humans, were also originally found in bats, camels and cattle, however no information is known about HCoV-HKU1 (Huynh et al. 2012; Davis et al. 2018) . Bats act as the prime reservoir to most of the CoVs, circulating in animals, which are not linked with the human infections. Such viruses have ability to mutate rapidly and transform into a novel CoV that can transmit to humans (de Wit et al. 2016) . (2002), when novel CoVs transmitted from bat to humans, resulted in a severe respiratory syndrome (SARS-CoV) (Luk et al. 2019; Drosten et al. 2003) . In Saudi Arabia (2012) another CoVs were transmitted from camels to humans, known as Middle East Respiratory Syndrome coronavirus (MERS-CoV) (Luk et al. 2019) . The current 2019 novel SARS-CoV-2, which emerged in China is a Betacoronavirus associated to the lineage B or sarbecovirus, a subgenus. Sequencing of SARS-CoV-2 revealed 87 -89% nucleotide similarity with bat SARS-related CoV (bat-SL-CoVZC45). The epidemic of SARS-CoV-2 was first announced from Wuhan city of China on 31 st Dec 2019, having a local seafood market as a primary source of the virus. From here the infected humans either symptomatic or asymptomatic carried forward and transmitted the virus by direct contact or respiratory droplets to cities and other countries, which finally led to a pandemic (Zhu et al. 2020; Chan et al. 2020 ).

Preparatory epidemiological information pointed that the symptomatic manifestation of COVID-19 in children is rare. As per the reports from Chinese Centers for Disease Control and Prevention as of March 2020, only 2% cases of less than 19 years have been found affected by SARS-CoV-2 (Table 1 & fig 1) . A study was conducted having 3 case series of SARS-CoV-2 infected children. The 1 st series had 20 children from Zhejiang (until 31 st Jan 2020), the 2 nd series had 34 children from Shenzhen (19 th Jan to 7 th Feb 2020) and the 3 rd series with nine infants from various provinces of China Chen, Fu, et al. 2020; ). Most of the clinical details were obtained from the 2 nd series, like, no children had any underlying disease, respiratory symptoms were seen in 65% children, mild symptoms in 26% and 9% were found asymptomatic. The 1 st case series was presented with mild to moderate fever, cough, rhinitis, diarrhea, headache and poor feeding, cyanosis, dyspnea in severe cases. The 3 rd series presented with fever in four infants. Almost all the children with manifested symptoms recovered within couple of weeks. No death is reported in children infected with SARS-CoV-2 till date (Chen, Fu, et al. 2020) .

Considering the epidemiology of the previous two outbreaks, it was identified that, although children are susceptible to infection by SARS-CoV, younger children comparatively had shown milder disease as compared to the 12 years of age and adolescents. It was reported that adolescent somehow resembled the clinical and radiological findings as adults and showed decline in their conditions as well (Leung, Kwan and Co, 2004) . As reported in a review by Banik, Khandekar, Rashid 2015 and Sehaibany et al 2017, MERS-CoV is predominantly prevalent among adults, but couple of cases among pediatric group were also reported, although as in case of SARs-CoV and COVID 19, most of them were asymptomatic. The diagnosis was mostly done during screening process of the adult family members, who were MERS-CoV positive.

Although there are no reasonable cases of children affected with COVID-19, but they could act as the carriers of virus. It is clearly evidenced that children are susceptible to SARS-CoV-2 contagion, but considerably without prominent disease, giving the chance that children could act as mediators for viral transmission and amplification. Thus, public and social health policies such as avoiding contacting with elderly group would be decided to avoid transfer and keep vulnerable people safe (Kelvin and Halperin, 2020) . There are "silent patients" which may stay undiagnosed and are able to propagate the virus to considerable groups of people. It seems that children may not be as susceptible to COVID-19, as adults, and even after contracting the virus, they may remain asymptomatic (Guoqing et al, 2020). milder symptoms compared to adults which is also seen early in outbreak of SARS-CoV and MERS-CoV infections (Hon et al. 2003; Alfaraj et al. 2019; Kwan et al. 2004; Wang, Yuan, et al. 2020; Wei et al. 2020; Chen, Guo, et al. 2020) . Additionally this study is the indication that mild symptoms or absence of severe symptoms in children may lead to misdiagnosis and will lead to skip the required test for SARS-CoV-2 and therefore, asymptomatic children might spread the disease (Guan et al. 2020) . A study has revealed that SARS-CoV-2 can be found in feces long after throat and nose swabs test negative. However, the maximum number of SARS-CoV-2 infected children, have been found as a part of family cluster outbreak. This is also in accordance with the previous outbreaks of SARS-CoV and MERS-CoV, which reported to have 50-80% and 32% of children, infected by household contact, respectively (Al-Tawfiq, Kattan, and Memish 2016; Wang, Yuan, et al. 2020 ).

Children have equal chances of becoming infected with SARS-CoV-2 as adults, although would have milder symptoms or completely asymptomatic as suggested by a recently published study in

March 2020 . Although, the role of children in spreading the virus is still to be unraveled. Also, till date, there is no evidence of vertical transmission of SARS-CoV-2, from mother to the infant (Chen, Guo, et al. 2020) .

Real time polymerase chain reaction (RT-PCR) of respiratory tract secretion is the basic diagnostic method for COVID-19 disease, which can detect higher loads of virus from lower respiratory tract secretion as compared to higher tract (Lee et al. 2017; Vabret et al. 2003) . Therefore, the initial negative suspected cases should be repeated for lower respiratory secretion. RT-PCR is used for genes that encodes the surface spike glycoprotein and internal RNA-dependent polymerase (Zhou et al. 2017) . Whole genome sequencing is also being used as a molecular detection test for the SARS-CoV-2 (Chan et al. 2020) .

There is no specific treatment recommended for children by neither WHO, nor the US CDC.

However, the aim of the treatment in children with COVID-19 is the prevention of organ failure, ARDS and hospital acquired infections. This is achieved by supportive treatment, which includes adequate intake of fluid, calories and ventilator support (Chen, Fu, et al. 2020) . The recommended treatment for HCoVs infected children is the oral lopinavir/ritonavir along with corticosteroids and aerosolized interferon alpha-2b and also intravenous immunoglobulin, in case of severe cases.

Lopinavir and ritonavir belong to the class of medications named as protease inhibitors. They are recommended to use in combination with other antivirals. Lopinavir/ritonavir may be considered for use as part of an investigational protocol for patients with COVID-19. Although, there is no evidence or recommendation from WHO about the benefit of above-mentioned therapies (Cao, Xia et al. 2020) . Most of the children with SARS-CoV-2 infection had been treated with only lopinavir/ritonavir without using immunoglobulins . 

Rapid and impactful measures for infection control are needed to minimize the spread of SARS-CoV-2. One of the most challenging tasks with COVID-19, is the containment of nosocomial transmission which is a potential threat among the children. Health care setups appear to enhance the chance of viral transmission because of infective droplets producing procedures like suctioning of the airways and intubation. Adequate and appropriate hospital sanitization is of paramount importance to control and restraint the hospital acquired COVID-19 infection. A well-known fact is the need of strict hand sanitization which can be achieved by using ethanol, isopropanol, etc. and minimal social gatherings (Bin et al. 2016; Leung et al. 2004 ).

The idea of immune memory provides previous exposures form existing immune function. The exposures include not only specific antigens exciting adaptive (specific) immune memory, but also preserved antigens related to molecular patterns, that mold innate (non-specific) immune responses for long period of life. It is not surprising that there is a major scale of external agents and environmental factors that influence and modulate the immune system, which is most easily identified in early life, a period of fast variable environments (MacGillivray and Kollmann, 2014).

The immune system is supposed to respond to harmful antigens such as viruses, bacteria and other pathogens. However, normal microbial flora, chemical agents, stress, and other factors can also elicit, frame or interact with the immune system. It is commonly reasonable that some of these interactions are physiological and requisites for a healthy immune system. While there are group of factors negatively influence, such as, immunosuppressive influence of UV irradiation, the artificially immunotoxin agents, such as polycyclic aromatic hydrocarbons, autoimmune or allergies affect negatively. Positive effects are derived from naturally contacting with natural bacterial flora, good lifestyle, and diet. There is a great communication between the environment and the immune system. Many environmental factors can be of effects on immune system such as such as bacteria, sun exposure, age, exercise, stress and air pollution (Esser, 2016) . It is thought that prior exposure to moderate coronaviruses may play a part in kids' comparative COVID-19 edge over adults. Children presence in environments of schoolyard, may be continuously producing antibodies to pathogens and those antibodies are variably enough to fight off COVID-

There is a significant modification of vaccine antibody levels among children and early life exposition to drinking water arsenic and lead in blood. Special differences were reported in children related to difference based on gender, only female group was susceptible to metal-related alteration in antibody concentrations. Weight against age, nutritional condition, did not show the link between vaccine antibody and the metal mixture (Welch et al, 2020) .

SARS-CoV-2 enter the host cell through binding of viral spike proteins to ACE2 receptors which exist on the host cell membrane. This increases the potential of infection susceptibility via expression of the target ACE2 receptor in exposed epithelium to virus. Children have more ACE level in serum than adults. Considering the opposite relation between ACE and ACE2, this variability reflects a lower level of ACE2 expression in children in comparison to adults. While adolescents had higher concentrations of blood ACE than adults and is interesting to observe that COVID-19 in the age group 10-19 years is only found in 1% in the Chinese group.

Epidemiological proofs show that SARS-CoV-2 in children is less intense than adults (Rodriguez et al, 1981; Skarstein, 2020; Wan et al, 2020) One of the most common parameters for the severity of the COVID-19 is the chronic illness, like high blood pressure, diabetes, and cardiovascular disease (Mizumoto et al. 2015) . Based on this fact, children appear to be at lower risk, due to absence of such aliments at young age. This trend has been also seen during SARS-CoV outbreak in 2002, with a relatively lower mortality rate and mild symptoms, compared to adults (Hon et al. 2003) . Innate immunity of the human body is critical and is the first line of defense for battling the infectious diseases. This defense mechanism shows an exponential decline in the later life span, which leads to increase in the incidence of infectious disease. For example, diseases like chickenpox and measles are fatal to adults, almost 25 times more than children (Rawson, Crampin, and Noah 2001) .

The adaptive immune mechanism is a slowly evolved defense system that recognizes specific agents and is prolonged in its action against the pathogens (Tregoning and Schwarze 2010) .

Research suggests that if a child has a strong innate defense to current virus, the chances of fight against the infection is more effective, with manifestation of only mild symptoms. The fact is that children also get caught with the respiratory infection, however they fight robustly and recover faster than the adults. The probable justification could be healthy respiratory tissues due to nonsmoking, less exposure to air pollution, etc. As also seen in previous outbreaks like SARS and MERS in 2003 and 2012, respectively, that the underlying diseases was one of the major causes for the increased rate of death among the adults. The co-occurring diseases could be diabetes, cardiovascular, obesity or any autoimmune disease. Among the adults, an acute respiratory distress syndrome (ARDS) is a condition, which is caused by detrimental immune response (de Wit et al. 2016 ) .The intricate imbalance of the immune system over activates the lungs and hence accumulating fluid in the alveoli. Under normal conditions, RBCs rush into these air sacs to pick up new oxygen, however on inflammation of these alveoli, the RBCs stop functioning, making it difficult to breathe. Therefore, the people with ARDS have higher death risk of coronavirus as seen in SARS coronavirus. This is also one of the reasons that frequency of fatality of COVID-19

is less in children, owing to non-presence of complicated immunological response, compared to adults. However, it is a subject of priority for the researchers to unravel the mechanism of action and outcome in children against the CoVs infection.

Interferon (IFN) is a glycoproteins cluster, synthesized by host infected cells as an antiviral response once the body is infected by virus. IFN is the first defense line in innate immunity against viral infection. Genetics and variable protein structures are bases to classify IFN into IFN-α, IFN-β, IFN-γ, etc. Interferons play essential role as antiviral factors via two mechanisms: (1) As innate immunity, IFN stimulates production of antiviral effector proteins, thus inhibit replication of invaded virus in the cells which are released to protect neighboring normal cells from viral invasion;

(2) activate T cellular immunity through supporting the proliferation and activation of an important T lymphocyte clonal named cytotoxic T lymphocyte, later activates natural killer (NK) and macrophage cells to remove the virus. Deficiency of body endogenous IFN may lead to a decrease in an antiviral response.

Children are subjected to viral infection since their immature immunity revealing lower levels of specific cellular and humoral immunity and IFN production (Shen et al, 2020) 

A study published by Miyamoto et al (2004) , reported that pandemic disease is dependent on acquired/vaccinated immunity and weather conditions that are catastrophic to several viruses such as severe acute respiratory syndrome corona virus (Miyamoto, Sahara, and Sugieda 2004) . The less effect of COVID-19 on children is not because of vaccines, as there is no significant cross reactivity against SARS-CoV, which indicates that decreased symptoms of SARS-CoV in children may be attributed to other reasons (Yu et al. 2007 ). Thymus gland may play a key role in this regard, as it is active in the childhood than adulthood. It is known that thymus housed mainly T lymphocyte, Sarah et al, (2016) reported that there are plasma cells generated by B lymphocyte which are residing in thymus, they studied the phonemic of these resident cells and their potential protective function against viral infections. It was found that starting from the first year of life, CD138(+) plasma cells begin to accumulate in perivascular space of thymus (PST), where they secrete immunoglobulin G (IgG) without additional activation and secrete IgG1 and IgG3 exclusively, the two main antibodies that able to fix the complement on IgG subclasses (Fig 2) .

Plasma cells in thymus comprise a high recurrence of cells reactive to popular viral proteins. It was revealed that an unknown function of the PST has an effective niche for viral-specific plasma cells. The PST is placed between the thymic epithelial zones and the blood circulation (Nuñez et al. 2016 ).

IgG3 and IgG1 are the main secreted IgG subclass by thymic plasma cells, with negligible IgG2 and IgG4 producing plasma cells. IgG3 and IgG1subclass have been found associated with the immunity against the common viral infections. Specific antibodies against viral antigens are produced by maximum plasma cells in infants less than 1 year and pediatric age group between 1 and 15 years. Moreover, the occurrence of plasma cells was increased in case of influenza and measles in children compared with the newborn thymus. Furthermore, it was concluded that the expression of chemokine receptor and CXCR3 elevates in the thymic B cells with increasing age and is localized in the thymic perivascular spaces (Kao et al. 2015 ) (Bordon 2017) . which are reactive to common viral proteins and IgG subclass with no function.

The COVID-19 disease has emerged as a pandemic and the current data reveals that children do not develop serious disease, that requires hospitalization compared to adults. The possible reasons for disparity in clinical severity between children and adults could be the difference in cytokine profile (having less interleukin 6 and myeloperoxidase) in the lungs of children. Additionally, thymus has a significant role with its resident plasma cells secreting functional antibodies fixing complements, which highly promote the immunity in the starting of early age. Also, the other possible factors involved in decreased clinical severity in pediatric age group could be less exposure to pollutants and increased incidence of viral upper respiratory tract infections, which may result in better immune response due to cross reactive antibodies against SARS-CoV-2.

However, further research is needed to understand the underlying mechanisms leading to decreased mortality in the pediatric age group.

Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea

Antibody responses: A thymic niche for plasma cells

An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV2)

National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus

Severe Acute Respiratory Syndrome Among Children

Human coronaviruses and other respiratory infections in young adults on a university campus: prevalence, symptoms, and shedding

Effects of multiple sources of genetic drift on pathogen variation within hosts

SARS and MERS: recent insights into emerging coronaviruses

COVID-19-New Insights on a Rapidly Changing Epidemic

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Environmental influences on the immune system

Middle East respiratory syndrome in children Dental considerations

Clinical characteristics of coronavirus disease 2019 in China

A COVID-19 Transmission within a family cluster by presymptomatic infectors in China

A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model

Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine

Clinical presentations and outcome of severe acute respiratory syndrome in children

HCoV-HKU1 Spike protein uses Oacetylated sialic acid as an attachment receptor determinant and employs HE protein as a receptor-destroying enzyme

Evidence supporting a zoonotic origin of human coronavirus strain NL63

Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein

A Monosaccharide Residue Is Sufficient to Maintain Mouse and Human IgG Subclass Activity and Directs IgG Effector Functions to Cellular Fc Receptors

COVID-19 in children: the link in the transmission chain

Severe acute respiratory syndrome can be mild in children

Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV

Evaluation of a real-time reverse transcription-PCR (RT-PCR) assay for detection of Middle East respiratory syndrome coronavirus (MERS-CoV) in clinical samples from an outbreak in South Korea in 2015

Infection control for SARS in a tertiary paediatric centre in Hong Kong

Molecular epidemiology, evolution and phylogeny of SARS coronavirus

Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus

The role of environmental factors in modulating immune responses in early life

Seroepidemiological analysis of influenza pandemics in Shizuoka Prefecture and all Japan

Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea

The human thymus perivascular space is a functional niche for viral-specific plasma cells

Genetic Drift Chapter In book: Brenner's Encyclopedia of Genetics

Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study

Antiviral activity of K22 against members of the order Nidovirales

Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data

Serum angiotensin-converting enzyme activity in normal children and in those with sarcoidosis

New insights into the antiviral effects of chloroquine

Therapeutic Approaches for COVID-19 Based on the Dynamics of Interferon-mediated Immune Responses

Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue

ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease

Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology

An outbreak of coronavirus OC43 respiratory infection in Normandy

The COVID-19 epidemic', Tropical Medicine & International Health

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS

Novel coronavirus infection in hospitalized infants under 1 year of age in China

Evaluating the effects between metal mixtures and serum vaccine antibody concentrations in children: a prospective birth cohort study'. Environ Health

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Characteristics of and important lessons from the Coronavirus Disease 2020. (COVID-19) Outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Children's vaccines do not induce cross reactivity against SARS-CoV

Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus

A novel coronavirus from patients with pneumonia in China

Authors sincerely acknowledge all the front-line health and other emergency